Chuangui Chen

Safety and effectiveness of pembrolizumab combined with paclitaxel and cisplatin as neoadjuvant therapy followed by surgery for locally advanced resectable (stage III) esophageal squamous cell carcinoma: a study protocol for a prospective, single-arm, single-center, open-label, phase-II trial (Keystone-001)

Xiaobin Shang, Gang Zhao, Fei Liang et al. · Annals of Translational Medicine · 2022 · 59 citations · Full text

Pembrolizumab Combined With Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy Followed by Surgery for Locally Advanced Oesophageal Squamous Cell Carcinoma: Protocol for a Multicentre, Prospective, Randomized-Controlled, Phase III Clinical Study (Keystone-002)

Xiaobin Shang, Wencheng Zhang, Gang Zhao et al. · Frontiers in Oncology · 2022 · 56 citations · Full text

The Expression of High Mobility Group Box 1 is Associated with Lymph Node Metastasis and Poor Prognosis in Esophageal Squamous Cell Carcinoma

Chuangui Chen, Peng Tang, Yu Zhentao · Pathology & Oncology Research · 2012 · 40 citations

Tumor Biology, Esophageal Cancer, Medicine +9

A prospective study of neoadjuvant pembrolizumab plus chemotherapy for resectable esophageal squamous cell carcinoma: The Keystone-001 trial

Xiaobin Shang, Yongjie Xie, Jinpu Yu et al. · Cancer Cell · 2024 · 34 citations

Surgical Oncology, Esophageal Cancer, Gastrointestinal Oncology +8

Safety and Efficacy of Apatinib Monotherapy for Unresectable, Metastatic Esophageal Cancer: A Single-Arm, Open-Label, Phase II Study

LI Yan-wei, Feng He, Peng Ren et al. · The Oncologist · 2020 · 33 citations · Full text